Trade Mark Journal No.2025/024 13 June 2025
WO0000001856645 (5)
Office of origin: United States of America
Date of International Registration:21 March 2025
Date of designation in the UK:
21 March 2025

The mark consists of a flame and a torch base.
3 Dimensional
International priority date claimed: 2 October 2024
(United States of America)
(98782482)
- Class 5
- Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.
Amylyx Pharmaceuticals, Inc.
Representative: Fish & Richardson P.C., PO Box 1022, Minneapolis MN 55440-1022, UNITED STATES OF AMERICA